HK1217206A1 - 疫苗 - Google Patents

疫苗

Info

Publication number
HK1217206A1
HK1217206A1 HK16105131.1A HK16105131A HK1217206A1 HK 1217206 A1 HK1217206 A1 HK 1217206A1 HK 16105131 A HK16105131 A HK 16105131A HK 1217206 A1 HK1217206 A1 HK 1217206A1
Authority
HK
Hong Kong
Prior art keywords
vaccine
Prior art date
Application number
HK16105131.1A
Other languages
English (en)
Inventor
Puntervoll Pl
Sommerfelt Halvor
Clements John
P Nataro James
Zhang Weiping
M Taxt Arne
Original Assignee
Bergen Teknologioverf�Ring As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bergen Teknologioverf�Ring As filed Critical Bergen Teknologioverf�Ring As
Publication of HK1217206A1 publication Critical patent/HK1217206A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK16105131.1A 2013-02-20 2016-05-05 疫苗 HK1217206A1 (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361767161P 2013-02-20 2013-02-20
US201361766958P 2013-02-20 2013-02-20
US201361850636P 2013-02-20 2013-02-20
US201361886242P 2013-10-03 2013-10-03
PCT/IB2014/000267 WO2014128555A2 (en) 2013-02-20 2014-02-20 Vaccine

Publications (1)

Publication Number Publication Date
HK1217206A1 true HK1217206A1 (zh) 2016-12-30

Family

ID=50336353

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16105131.1A HK1217206A1 (zh) 2013-02-20 2016-05-05 疫苗

Country Status (8)

Country Link
US (1) US10166279B2 (zh)
EP (1) EP2958935B1 (zh)
CN (1) CN105658661B (zh)
DK (1) DK2958935T3 (zh)
ES (1) ES2743431T3 (zh)
HK (1) HK1217206A1 (zh)
PL (1) PL2958935T3 (zh)
WO (1) WO2014128555A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722569B2 (en) 2012-07-05 2020-07-28 Children's Medical Center Corporation Bacterial biofilm matrix as a platform for protein delivery
WO2017219004A2 (en) * 2016-06-17 2017-12-21 Children's Medical Center Corporation Biofilm matrix-boosted vaccine
CN106442988B (zh) * 2016-10-08 2018-03-20 扬州大学 产肠毒素大肠杆菌etec f4菌毛直接受体蛋白猪氨肽酶n功能结合域
WO2020039387A1 (en) 2018-08-24 2020-02-27 Vestlandets Innovasjonsselskap As (Vis) Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987237A (en) 1983-08-26 1991-01-22 Ribi Immunochem Research, Inc. Derivatives of monophosphoryl lipid A
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9717652D0 (en) 1997-08-20 1997-10-22 Nycomed Imaging As Method
US7772188B2 (en) * 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US20120064114A1 (en) 2008-10-21 2012-03-15 Emergent Product Development United Kingdom Use of e. coli surface antigen 3 sequences for the export of heterologous antigens

Also Published As

Publication number Publication date
CN105658661A (zh) 2016-06-08
DK2958935T3 (da) 2019-09-16
CN105658661B (zh) 2020-07-24
WO2014128555A3 (en) 2015-02-26
PL2958935T3 (pl) 2020-03-31
EP2958935A2 (en) 2015-12-30
US10166279B2 (en) 2019-01-01
WO2014128555A2 (en) 2014-08-28
ES2743431T3 (es) 2020-02-19
EP2958935B1 (en) 2019-07-03
US20160220654A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
IL276210B1 (en) Mers-cov vaccine
IL279395A (en) A vaccine
ZA201508642B (en) Malaria vaccine
GB201315946D0 (en) Oncology vaccine
GB201301085D0 (en) Glycoconjugate Vaccine
AU353643S (en) Stamphousing
HK1217206A1 (zh) 疫苗
GB201301329D0 (en) Fluidfoil
HK1216149A1 (zh) 彎曲杆菌疫苗
GB201320646D0 (en) Vaccine
GB201315556D0 (en) Vaccine
AU4977P (en) Harrosy Gaura lindheimeri
GB201417087D0 (en) No detials
AU353328S (en) Kettlebell
AU353331S (en) Kettlebell
AU353330S (en) Kettlebell
AU353329S (en) Kettlebell
AU353327S (en) Kettlebell
AU353326S (en) Kettlebell
AU353325S (en) Kettlebell
GB201310280D0 (en) Odontalgic preparation
AP00812S1 (en) Stumbelbloc
AU2013231V (en) Bonsca7200 Scaevola aemula
AU353341S (en) Playsuit
AU354283S (en) Playsuit